Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions.
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapyAttitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls.Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice.Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention.Cognitive function in cancer survivors: analysis of the 1999-2002 National Health and Nutrition Examination SurveyCognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.Cognitive functioning in breast cancer survivors: a controlled comparison.Self-reported cognitive impairment in patients with cancer.Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.'Chemobrain': concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study.Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.Coping with cancer-related cognitive dysfunction: a scoping review of the literature.Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients.Cancer Related Fatigue and Quality of Life in Patients with Advanced Prostate Cancer Undergoing Chemotherapy.PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain.Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study.Exploring the use of the survivorship consult in providing survivorship care.Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial.Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.Prechemotherapy alterations in brain function in women with breast cancer.The effects of chemotherapy on Useful Field of View (UFOV) in younger and older breast cancer patients.Tailored chemotherapy doses based on toxicity in breast cancer result in similar quality of life values, irrespective of given dose levels.Long-term sequelae after cancer therapy--a necessary consequence of success?
P2860
Q21146752-89DFAB88-BC48-4975-8FD3-9D9265B7D160Q30249112-39F1F0B2-B5D8-4A7D-A4AA-99FF96FC9623Q34006211-625BA478-0E82-4C93-B7A0-9515B3E2A4C4Q34048798-B189236C-9BC4-45B6-8A12-5C065D877753Q34065038-D597D3C9-769B-44F9-9BE6-0A5496CDC35EQ36440620-4BC2F204-3230-4C05-89D6-042C9FB6C84DQ36608806-02C030C5-41B0-4E51-8BEF-3E59C673EB24Q36695170-B1D88094-9348-463A-9694-3DD6531EBBFFQ36757041-22AE2FF8-88CF-420E-8772-3EAC4D81F6D6Q36957306-AA0A10CA-D3C5-4DE8-A027-6E24694A9743Q37067793-95B9322D-94A8-4D6C-B965-DAE2705037BBQ37121868-9908DAE6-2B04-4469-A6F0-F53219B54C80Q37157773-21392212-9188-445B-95B7-3F0CC6755CF4Q37476545-A2929699-23CB-4C74-8432-D629896AD400Q37576583-865357D8-546A-4C6C-890A-C4569B9E0BA7Q37858658-9262996B-4D38-489A-97AD-A4756A2392B4Q37976412-CDD23E32-469C-4314-BEB1-5DF7835A79AAQ38000038-71343CEE-B3EB-47F3-B338-370A5E6ACDB2Q38426172-90601989-0432-49BE-93B0-00227E0EBC84Q38891759-AD9EC82C-3D86-4D1D-8F02-0A7313132F6EQ39917062-E9FE56A7-1DAD-4054-A466-37EAFB625C79Q42178208-B5896B05-CC5A-4470-BED6-F5F15ABFD4BBQ43626249-DEBB55BB-5DC6-4019-903C-6301E7BD2603Q44285083-CD333AF4-97AE-46F1-A9C3-8E54676E6175Q46085538-88D7CC7E-C007-45CB-AA25-8DC7776B910CQ47745329-B94E2F25-B0F8-4156-AC3A-7A0EF8561838Q48499374-B731268D-FE05-40BF-813E-9976D7B8BB8FQ48707946-E24C368E-904E-4737-9448-446779220B8FQ53050079-F7DCBCD4-A1BF-47E6-8E51-75D1EC9F6056Q54401193-3F82EF1B-8313-4848-B036-E3CE16D4208A
P2860
Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Adjuvant breast cancer treatme ...... ledge and research directions.
@ast
Adjuvant breast cancer treatme ...... ledge and research directions.
@en
type
label
Adjuvant breast cancer treatme ...... ledge and research directions.
@ast
Adjuvant breast cancer treatme ...... ledge and research directions.
@en
prefLabel
Adjuvant breast cancer treatme ...... ledge and research directions.
@ast
Adjuvant breast cancer treatme ...... ledge and research directions.
@en
P2860
P356
P1476
Adjuvant breast cancer treatme ...... ledge and research directions.
@en
P2093
Jürg Bernhard
Kelly-Anne Phillips
P2860
P304
P356
10.1093/JNCI/95.3.190
P407
P577
2003-02-01T00:00:00Z